/MGRM

MGRM Stock - Monogram Orthopaedics, Inc.

Q: What is the analyst price target for MGRM?

Analyst price target information is not currently available for MGRM.

Q: What is MGRM's market cap?

Market capitalization information is not currently available for MGRM.

Healthcare|Medical - Devices|NASDAQ

$6.00-1.80%

$0.11 (-1.80%) • Oct 7

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+-10.0%upside

Target: $5.40

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for MGRM

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.69

52W High$6.42

52W Low$1.92

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	N/A	$365,000	N/A	$628,246	N/A
Gross Profit	$-430,000	$365,000	$-386,686	$169,571	$-95,694
Gross Margin	N/A	100.0%	N/A	27.0%	N/A
Operating Income	$-15,310,000	$-17,268,029	$-10,613,147	$-10,277,636	$-6,850,738
Net Income	$-16,328,000	$-13,745,217	$-13,690,947	$-11,814,968	$-9,068,006
Net Margin	N/A	-3765.8%	N/A	-1880.6%	N/A
EPS	$-0.50	$-0.61	$-0.47	$-0.40	$-0.31

Company Overview

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Visit Website

Rating Distribution

Strong Buy

Buy / Outperform

100%

Hold / Neutral

Sell / Underperform

Analyst Consensus🟢 Bullish

1 Bullish0 Neutral/Bearish

Price Targets

Average Target

↓ 33.3% Downside

Now

Low

Average

High

Based on 1 analyst

Recent Analyst Actions

Date	Firm	Action	Rating	Price Target
December 9th 2024	ROTH MKM	Initiation	Buy	$4

Earnings History & Surprises

MGRM

Beat Rate

43%

Last 7 quarters

Avg Surprise

-15.5%

EPS vs Estimate

Beats / Misses

3/4

Last 12 quarters

Latest EPS

$-0.16

Q4 2025

EPS Surprise History

Q1 24

No data

Q2 24

+8.3%

$-0.11vs$-0.12

Q3 24

-22.2%

$-0.11vs$-0.09

Q4 24

-33.3%

$-0.16vs$-0.12

Q1 25

+27.3%

$-0.08vs$-0.11

Q2 25

+16.7%

$-0.10vs$-0.12

Q3 25

-45.5%

$-0.16vs$-0.11

Q4 25

-60.0%

$-0.16vs$-0.10

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2025	Nov 13, 2025	$-0.10	$-0.16	-60.0%	✗ MISS
Q3 2025	Aug 15, 2025	$-0.11	$-0.16	-45.5%	✗ MISS
Q2 2025	May 14, 2025	$-0.12	$-0.10	+16.7%	✓ BEAT
Q1 2025	Mar 12, 2025	$-0.11	$-0.08	+27.3%	✓ BEAT
Q4 2024	Nov 14, 2024	$-0.12	$-0.16	-33.3%	✗ MISS
Q3 2024	Aug 14, 2024	$-0.09	$-0.11	-22.2%	✗ MISS
Q2 2024	May 13, 2024	$-0.12	$-0.11	+8.3%	✓ BEAT
Q1 2024	Mar 15, 2024	—	$-0.09	—	—
Q4 2023	Nov 8, 2023	—	$-0.03	—	—
Q3 2023	Aug 9, 2023	—	$-0.27	—	—
Q2 2023	Jun 6, 2023	—	$-0.40	—	—
Q4 2022	Dec 31, 2022	—	$-0.32	—	—
Q3 2022	Sep 30, 2022	—	$-0.14	—	—
Q2 2022	Jun 30, 2022	—	$-0.06	—	—
Q1 2022	Mar 31, 2022	—	$-0.15	—	—
Q4 2021	Dec 31, 2021	—	$-0.34	—	—
Q3 2021	Sep 30, 2021	—	$-0.34	—	—
Q2 2021	Jun 30, 2021	—	$-0.27	—	—
Q1 2021	Mar 31, 2021	—	$-0.27	—	—
Q4 2020	Dec 31, 2020	—	$-0.20	—	—

Frequently Asked Questions about MGRM

What is MGRM's current stock price?

Monogram Orthopaedics, Inc. (MGRM) is currently trading at $6.00 per share. The stock has moved -1.80% today.

What is the analyst price target for MGRM?

The average analyst price target for MGRM is $5.40, based on 1 analyst.

What sector is Monogram Orthopaedics, Inc. in?

Monogram Orthopaedics, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.

What is MGRM's market cap?

Monogram Orthopaedics, Inc. has a market capitalization of $0.24 billion, making it a small-cap company.

Does MGRM pay dividends?

No, Monogram Orthopaedics, Inc. does not currently pay a dividend to shareholders.